186 related articles for article (PubMed ID: 3548089)
1. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
Angelkort B
Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
Turowski A; Schmidt HH; Sternitzky R
Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
[No Abstract] [Full Text] [Related]
3. [Hemorheologic therapy in peripheral arterial occlusive disease].
Kiesewetter H; Jung F
Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
[TBL] [Abstract][Full Text] [Related]
4. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
Sternitzky R; Seige K
Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
[TBL] [Abstract][Full Text] [Related]
5. Hemorheology and peripheral vascular diseases: a new therapeutic approach.
Müller R
J Med; 1981; 12(4):209-35. PubMed ID: 7031157
[TBL] [Abstract][Full Text] [Related]
6. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
Runge E; Thiele P
Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic consequences of hemorheologic research].
Ernst E
Wien Med Wochenschr; 1989 Dec; 139(24):569-80. PubMed ID: 2696217
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
Schweiger H; Ortmeier CJ
Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
[TBL] [Abstract][Full Text] [Related]
9. [Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
Störmer B; Kleinschmidt F; Loose D; Kremer K
Dtsch Med Wochenschr; 1978 Apr; 103(16):694-8. PubMed ID: 639718
[TBL] [Abstract][Full Text] [Related]
10. [Training by walking and drug therapy of peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
[No Abstract] [Full Text] [Related]
11. Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.
Angelkort B
Ric Clin Lab; 1981; 11 Suppl 1():215-21. PubMed ID: 7188109
[TBL] [Abstract][Full Text] [Related]
12. [Hemorheologic therapy applications in coronary heart disease].
Leschke M; Motz W; Strauer BE
Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline -- a biomedical profile.
Müller R
J Med; 1979; 10(5):307-29. PubMed ID: 393789
[TBL] [Abstract][Full Text] [Related]
14. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
Ehrly AM
J Med; 1979; 10(5):331-8. PubMed ID: 294470
[No Abstract] [Full Text] [Related]
15. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
Angelkort B; Doppelfeld E
Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
[TBL] [Abstract][Full Text] [Related]
16. Drug therapy for peripheral arterial disease.
Naide D
Am Fam Physician; 1986 Sep; 34(3):215-7. PubMed ID: 3751848
[No Abstract] [Full Text] [Related]
17. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
Trübestein G; von Bary S; Breddin K; Diehm C; Gruss JD; Heinrich H; Horsch S; Kriessmann A; Maass U; Martin M
Vasa Suppl; 1989; 28():44-9. PubMed ID: 2692200
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
Benignetti G; Fabbri F; Benvenuti C
Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
[No Abstract] [Full Text] [Related]
19. [Correction of disorders of hemorheology and microcirculation during surgical treatment of patients with tetralogy of Fallot].
Tsyganiĭ AA; Kvasha AI
Anesteziol Reanimatol; 1988; (2):10-3. PubMed ID: 3407992
[No Abstract] [Full Text] [Related]
20. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
Angelkort B
Med Welt; 1979 Aug; 30(34):1239-43. PubMed ID: 491921
[No Abstract] [Full Text] [Related]
[Next] [New Search]